Atlas Trials

The Safety and Efficacy Test of Immuncell-LC to Treat Refractory Metastatic Colorectal Cancer

Clinical trial NCT03220984 · UNKNOWN

Trial details

NCT number
NCT03220984
Sponsor
Gangnam Severance Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2017-03-16
Primary completion
2019-03-15
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.